AstraZeneca Commits $2.5 Billion to Launch New R&D Hub in Beijing, Strengthening Global Presence

AstraZeneca announces a $2.5 billion investment to establish its second R&D center in Beijing, aiming to employ 1,700 personnel. The initiative includes partnerships with Beijing's...